SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: Is there a benefit for PPV in early response assessment by FDG-PET?-Reference-Cited by-同舟云学术

SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: Is there a benefit for PPV in early response assessment by FDG-PET?

Published:2011-12-20 Issue:3 Volume:59 Page:475-480
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Furth Christian,Meseck Robert M.,Steffen Ingo G.,Schoenberger Stefan,Denecke Timm,Henze Günter,Hautzel Hubertus,Hofheinz Frank,Großer Oliver,Hundsdoerfer Patrick,Amthauer Holger,Ruf Juri

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference25 articles.

1. Evaluation of interim-PET response criteria in paediatric Hodgkin lymphoma - Results for dedicated assessment criteria in a blinded, dual-centre read;Furth;Ann Oncol,2011

2. Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate;Levine;J Pediatr Hematol Oncol,2006

3. Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma;Meany;Pediatr Blood Cancer,2007

4. Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients;Miller;J Comput Assist Tomogr,2006

5. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas;Hernandez-Pampaloni;Pediatr Radiol,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of SUV with Changing the Dose Amount in F18-FDG PET/CT of Pediatric Lymphoma Patients;Current Radiopharmaceuticals;2023-06

2. Bildgebende Diagnostik von malignen Lymphomen*;InFo Hämatologie + Onkologie;2020-10

3. Bildgebende Diagnostik von malignen Lymphomen;Der Radiologe;2020-04-02

4. 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome;Clinical Nuclear Medicine;2019-10-31

5. Metabolic Tumor Volume Metrics in Lymphoma;Seminars in Nuclear Medicine;2018-01